Business · 03/01/2025
FDA Announces Public Meeting on Pediatric Drug and Biologic Development
The FDA is seeking input from various stakeholders on the implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, with the goal of informing a report to Congress on pediatric drug and biologic development and labeling.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →